Vraylar (cariprazine) is a prescription drug that’s used to treat certain mental health conditions, such as schizophrenia. The drug comes as a capsule that you swallow. It’s usually taken once ...

Adderall (amphetamine/dextroamphetamine) is a brand-name drug prescribed for ADHD and narcolepsy in adults and some children. Adderall comes in two forms. The dosage ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Augmentin (amoxicillin/clavulanate potassium) is a brand-name drug prescribed for specific bacterial infections in adults and children. Augmentin comes as an oral ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2.

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side effects ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

The report, published on 16 September in The Lancet 1, found that between 1990 and 2021, more than one million people died from drug-resistant infections each year, and this could increase to ...

Too little radiation can be ineffective, while too much can be harmful. Therefore, utmost care must be taken when administering a radiation dose. The IAEA provides calibration and postal dose audit ...

By Noah Weiland Noah Weiland has written about the public health policies that seek to address drug overdoses. Drug overdose deaths are decreasing sharply across the country, according to recent ...

Here's what you should know about doxycycline for dogs, including dosage information, possible side effects and drug ...

In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain ...